8-K: Definitive Healthcare Terminates Spectrum Nominating Agreement

Definitive Healthcare Corp. and SE VII DHC AIV, L.P. (Spectrum) have terminated their Nominating Agreement, ending Spectrum's right to designate a board nominee.

Summary

• Definitive Healthcare Corp. announced the termination of its Nominating Agreement with SE VII DHC AIV, L.P. (Spectrum).
• This agreement, originally dated September 17, 2021, granted Spectrum the right to nominate one director to the Company's board as long as they beneficially owned at least 5% of the outstanding common stock.
• Jeff Haywood, the Spectrum Designee, resigned from the board on March 30, 2026.
• The termination agreement was entered into on April 3, 2026, permanently and irrevocably terminating the Nominating Agreement.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as it signifies a procedural change in corporate governance rather than a direct financial performance indicator.

Positives

• The termination of the Nominating Agreement simplifies board composition and governance structure.
• The company is moving forward without the obligation to accommodate a specific stakeholder's board nomination.

Negatives

• The resignation of Jeff Haywood as the Spectrum Designee indicates a potential shift in Spectrum's relationship or investment in Definitive Healthcare.
• The termination of the agreement suggests a potential reduction in Spectrum's influence or stake in the company.

Risks

• Potential for future disagreements or strategic misalignment if Spectrum remains a significant shareholder without board representation.
• Uncertainty regarding Spectrum's future investment strategy and its impact on Definitive Healthcare's stock.

Future Outlook

No specific future outlook or guidance is provided in this filing, as it solely pertains to the termination of a material definitive agreement.

Management Comments

• The termination agreement permanently and irrevocably terminated the Nominating Agreement in its entirety.

Industry Context

StockSavvy.ai notes that the termination of such nominating agreements is common as investor stakes change or strategic alignments evolve, often leading to a more streamlined board structure for the company.

Management Changes

Corporate Governance

Related Party Transactions

• Termination of the Nominating Agreement between Definitive Healthcare Corp. and SE VII DHC AIV, L.P. (Spectrum).

Stakeholder Impact

• Shareholders: May see a more streamlined board selection process, potentially leading to greater board independence.
• Spectrum: Loses its formal right to nominate a director, which could impact its ability to influence company strategy directly through board representation.

Next Steps

• Definitive Healthcare will continue to operate with its current board composition.
• Spectrum will no longer have the right to designate a nominee to the board.

Key Dates

Keywords

Definitive Healthcare, Spectrum, Nominating Agreement, Board of Directors, Corporate Governance, SEC Filing, 8-K, Director Resignation